Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 ...

Retrieved on: 2024-10-14 11:42:00

Tags for this article:

Click the tags to see associated articles and topics

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 .... View article details on hiswai:

Excerpt

"We remain focused on advancing our pipeline of programs targeting the immune system ... Q32 Bio's program for adaptive immunity, bempikibart ...

Article found on: www.kilgorenewsherald.com